Baseline characteristics of the subjects. by Changzhi Liu (518454)

“…The incidence of fractures was significantly greater among participants with low RC levels than among those with high RC levels (6.4% vs. 3.1%, P < 0.01). …”

Summary of related studies. by Most. Fatematuz Zohora (19429152)

“…To address these challenges, we propose the Dynamic Banker’s Deadlock Avoidance Algorithm (DBDAA). …”

Time complexity of different safety algorithms. by Most. Fatematuz Zohora (19429152)

“…To address these challenges, we propose the Dynamic Banker’s Deadlock Avoidance Algorithm (DBDAA). …”

Process execution halted due to deadlock. by Most. Fatematuz Zohora (19429152)

“…To address these challenges, we propose the Dynamic Banker’s Deadlock Avoidance Algorithm (DBDAA). …”

Classification of panels after the impact test. by Tek Raj Gyawali (20550560)

“…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

XXXX. by Tek Raj Gyawali (20550560)

“…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

Compounds of Type III Portland cement. by Tek Raj Gyawali (20550560)

“…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

XXXX. by Tek Raj Gyawali (20550560)

“…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

Impact test procedure on panel. by Tek Raj Gyawali (20550560)

“…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

Summarized data of cost calculation. by Tek Raj Gyawali (20550560)

“…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

Mixing and flow condition of REC15HDM. by Tek Raj Gyawali (20550560)

“…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

External and internal view of the Omni mixer [ by Tek Raj Gyawali (20550560)

“…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

Required properties of sand. by Tek Raj Gyawali (20550560)

“…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

Classification of panels after the impact test. by Tek Raj Gyawali (20550560)

“…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

Static loading procedure. by Tek Raj Gyawali (20550560)

“…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”

Novel Small-Molecule miR-124 Inducer Acts as “a Physiological Brake” of Inflammation in Ulcerative Colitis by Targeting the PIK3R2/PI3K/Akt Axis by Tiantian Wang (1688881)

“…This study identified FHND5032, a novel small-molecule miR-124 inducer, as a potent therapeutic candidate for UC. We found that FHND5032 significantly upregulated miR-124 expression in macrophages, surpassing the clinical-stage comparator ABX464 in vitro and in vivo. …”

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”

Primer pairs for RT-qPCR. by Yoichi Kurokawa (22290520)

“…Conversely, exposure to endogenous prooxidants (dopamine and adrenaline), certain food-derived polyphenols (chrysin and 3-<i><i>O</i></i>-methylquercetin), or 1,2-naphthoquinone led to a significant decrease (<0.5-fold) in Rmst expression. …”